← Leaderboards
Ellen W Seely
Brigham And Women'S Hospital
$4,806,814
Attributed
$5,563,368
Total exposure
13
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $829K · FY2005–22$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$5,563,368 · 13
By mechanism
K24$1,744,360 · 2
R44$1,184,546 · 1
R01$1,035,188 · 1
R56$629,509 · 1
P50$464,964 · 1
R43$328,562 · 1
Top collaborators
- Dharma E Cortes4 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Ravi Thadhani$43,973,148
- Anand Vaidya$13,102,242
- Kathryn M Rexrode$18,811,565
- Rulla M Tamimi$15,389,173
- Jonathan S Williams$3,996,120
Others in their field
Top investigators on “Hypertension”
- Chanza Baytop · Westat, Inc.$271,217,917
- Paula Darby Lipman · Westat, Inc.$52,914,492
- Walter N Kernan · Yale University$42,197,025
- Rohit Varma · University Of Southern California$35,266,606
- Susan S Redline · Brigham And Women'S Hospital$35,248,244
- Marlene Rabinovitch · Stanford University$34,807,202
Research focus
HypertensionEstradiolPatient Oriented ResearchHuman SubjectClinical ResearchPostmenopauseWomanWomen'S HealthHuman Therapy EvaluationFemaleHormone TherapyRenin Angiotensin SystemBaseDiabetes MellitusPregnancyProgramsGestational DiabetesGenetic PolymorphismEstrogensMenopauseNon-Insulin-Dependent Diabetes MellitusBlood PressureRecording Of Previous EventsGenetic Susceptibility
Grant awards (33)
Integrated Clinic and Patient Technology-Enabled Program to Reduce the Risks of Cardiometabolic Disease Among Latinas with Prior Pregnancy Complications$328,562
R43 · FY2022 · MD
Mobile Health App to Reduce Diabetes in Latina Women with Prior Gestational Diabetes$517,328
R44 · FY2020 · MD
Mobile Health App to Reduce Diabetes in Latina Women with Prior Gestational Diabetes$184,794
R44 · FY2020 · MD
Mobile Health App to Reduce Diabetes in Latina Women with Prior Gestational Diabetes$482,424
R44 · FY2019 · MD
Angiotensin II sensitivity, vascular dysfunction and prior preeclampsia$629,509
R56 · FY2014 · HL · contact PI
Unique cardiovascular Risk Factors in Women Research and Mentoring Progam$199,519
K24 · FY2014 · HL · contact PI
Unique cardiovascular Risk Factors in Women Research and Mentoring Progam$199,519
K24 · FY2013 · HL · contact PI
Unique cardiovascular Risk Factors in Women Research and Mentoring Progam$199,519
K24 · FY2012 · HL · contact PI
Unique cardiovascular Risk Factors in Women Research and Mentoring Progam$199,519
K24 · FY2011 · HL · contact PI
Unique cardiovascular Risk Factors in Women Research and Mentoring Progam$198,634
K24 · FY2010 · HL · contact PI
Blood Pressure in Postmenopausal Women: A GCRC Study$149,530
K24 · FY2007 · RR · contact PI
Blood Pressure in Postmenopausal Women: A GCRC Study$149,530
K24 · FY2006 · RR · contact PI
FEMALE GENDER AND ITS INFLUENCE ON GENETIC EXPRESSION OF RISK GENES$68,139
M01 · FY2006 · RR · contact PI
DIETARY SALT INTAKE AND VASCULAR FUNCTION IN HEALTHY MEN$25,828
M01 · FY2006 · RR · contact PI
Female gender &expression of risk genes in hypertension$226,986
P50 · FY2005 · HL
Blood Pressure in Postmenopausal Women: A GCRC Study$149,530
K24 · FY2005 · RR
FEMALE GENDER AND ITS INFLUENCE ON GENETIC EXPRESSION OF RISK GENES$41,083
M01 · FY2005 · RR
GENETIC EXPRESSION OF RISK GENES IN HYPERTENSION$259,500
R01 · FY2004 · HL
Blood Pressure in Postmenopausal Women: A GCRC Study$149,530
K24 · FY2004 · RR
Female Gender--Influence on Genetic Expression of Risk G$31,987
M01 · FY2004 · RR
Continuous Glucose Monitoring in Lactating Women$9,202
M01 · FY2004 · RR
GENETIC EXPRESSION OF RISK GENES IN HYPERTENSION$259,500
R01 · FY2003 · HL
Blood Pressure in Postmenopausal Women: A GCRC Study$149,530
K24 · FY2003 · RR
GENETIC EXPRESSION OF RISK GENES IN HYPERTENSION$259,125
R01 · FY2002 · HL
Female gender &expression of risk genes in hypertension$237,978
P50 · FY2002 · HL
EFFECT OF IRBESARTAN PLUS ESTRACE COMPARED TO IRBESARTAN ALONE$0
M01 · FY2002 · RR
DISORDERED SODIUM REGULATION AND HYPERTENSIVE COMPLICATIONS OF PREGNANCY$0
M01 · FY2002 · RR
GENETIC EXPRESSION OF RISK GENES IN HYPERTENSION$257,063
R01 · FY2001 · HL
DISORDERED SODIUM REGULATION AND HYPERTENSIVE COMPLICATIONS OF PREGNANCY$0
M01 · FY2001 · RR
Female gender &expression of risk genes in hypertension$0
P50 · FY2001 · HL
EFFECT OF IRBESARTAN PLUS ESTRACE COMPARED TO IRBESARTAN ALONE$0
M01 · FY2001 · RR
DISORDERED SODIUM REGULATION AND HYPERTENSIVE COMPLICATIONS OF PREGNANCY$0
M01 · FY2000 · RR
EFFECT OF IRBESARTAN PLUS ESTRACE COMPARED TO IRBESARTAN ALONE$0
M01 · FY2000 · RR